Partial suppression by pyridinolcarbamate of growth and necrosis of atherosclerotic lesions in swine subjected to an atherogenic regimen that produces advanced lesions.
D000818:Animals; D001011:Aorta / Q000378:metabolism; D001012:Aorta, Abdominal / Q000473:pathology; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D002114:Calcinosis; D002219:Carbamates / Q000627:therapeutic use*; D002784:Cholesterol / Q000378:metabolism; D002791:Cholesterol, Dietary; D004036:Diet, Atherogenic; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D009336:Necrosis; D011727:Pyridinolcarbamate / Q000627:therapeutic use*; D013552:Swine
D002219:Carbamates; D002791:Cholesterol, Dietary; D011727:Pyridinolcarbamate; D002784:Cholesterol; D006918:Hydroxyurea